These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 18271062

  • 1. Re: Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.
    Bennett M, Yegena S, Dave HP, Schechter GP.
    Hematol Oncol; 2008 Jun; 26(2):114. PubMed ID: 18271062
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab.
    Bennett M, Schechter GP.
    Semin Hematol; 2010 Apr; 47(2):143-7. PubMed ID: 20350661
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis.
    Niscola P, Palumbo R, Scaramucci L, Tendas A, Cupelli L, Giovannini M, Piccioni D, Dentamaro T, Perrotti AP, de Fabritiis P.
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):759-60. PubMed ID: 18500519
    [No Abstract] [Full Text] [Related]

  • 4. Remission induction therapy containing rituximab markedly improved the outcome of untreated mature B cell lymphoma.
    Nagai H, Yano T, Watanabe T, Uike N, Okamura S, Hanada S, Kawano F, Sunami K, Inoue N, Sawamura M, Nishiura T, Hotta T, Horibe K.
    Br J Haematol; 2008 Dec; 143(5):672-80. PubMed ID: 18950459
    [Abstract] [Full Text] [Related]

  • 5. Rituximab monotherapy for splenic marginal zone lymphoma.
    Bennett M, Sharma K, Yegena S, Gavish I, Dave HP, Schechter GP.
    Haematologica; 2005 Jun; 90(6):856-8. PubMed ID: 15951303
    [Abstract] [Full Text] [Related]

  • 6. Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.
    Kalpadakis C, Pangalis GA, Dimopoulou MN, Vassilakopoulos TP, Kyrtsonis MC, Korkolopoulou P, Kontopidou FN, Siakantaris MP, Dimitriadou EM, Kokoris SI, Tsaftaridis P, Plata E, Angelopoulou MK.
    Hematol Oncol; 2007 Sep; 25(3):127-31. PubMed ID: 17514771
    [Abstract] [Full Text] [Related]

  • 7. [Low-grade cutaneous B-cell lymphoma: Failure of intralesional rituximab (Mabthera)].
    Abasq C, Duval-Modeste AB, Courville P, Joly P.
    Ann Dermatol Venereol; 2008 Sep; 135(6-7):509-11. PubMed ID: 18598807
    [No Abstract] [Full Text] [Related]

  • 8. [Splenic marginal zone lymphoma associated with autoimmune hemolytic anemia treated with splenectomy and rituximab].
    Miztani M, Noda T, Umino A, Tanigawa M, Taniguchi M, Tamaki S, Tsuji K.
    Rinsho Ketsueki; 2007 Nov; 48(11):1489-91. PubMed ID: 18080507
    [Abstract] [Full Text] [Related]

  • 9. Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia.
    Fabbri A, Gozzetti A, Lazzi S, Lenoci M, D'Amuri A, Leoncini L, Lauria F.
    Clin Lymphoma Myeloma; 2006 May; 6(6):496-9. PubMed ID: 16796783
    [Abstract] [Full Text] [Related]

  • 10. Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine.
    Manner H, Jung B, Tonassi L, Hackenberg U, Plum N, Josten KM, Kirchmaier CM, Frickhofen N.
    Am J Med Sci; 2008 May; 335(5):394-7. PubMed ID: 18480659
    [Abstract] [Full Text] [Related]

  • 11. Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
    Else M, Marín-Niebla A, de la Cruz F, Batty P, Ríos E, Dearden CE, Catovsky D, Matutes E.
    Br J Haematol; 2012 Nov; 159(3):322-8. PubMed ID: 23016878
    [Abstract] [Full Text] [Related]

  • 12. Rituximab is effective for human herpesvirus-8-negative primary effusion lymphoma with CD20 phenotype associated hepatitis C virus-related liver cirrhosis.
    Takao T, Kobayashi Y, Kuroda J, Omoto A, Nishimura T, Kamitsuji Y, Fukiya E, Nakamura C, Kimura S, Yoshikawa T.
    Am J Hematol; 2004 Dec; 77(4):419-20. PubMed ID: 15551361
    [No Abstract] [Full Text] [Related]

  • 13. Splenic marginal zone lymphoma: disease features and management.
    Matutes E.
    Expert Rev Hematol; 2013 Dec; 6(6):735-45. PubMed ID: 24168526
    [Abstract] [Full Text] [Related]

  • 14. Pediatric primary cutaneous marginal zone B-cell lymphoma treated with intralesional rituximab.
    Park MY, Jung HJ, Park JE, Kim YC.
    Eur J Dermatol; 2010 Dec; 20(4):533-4. PubMed ID: 20542839
    [No Abstract] [Full Text] [Related]

  • 15. Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab.
    Morales AV, Advani R, Horwitz SM, Riaz N, Reddy S, Hoppe RT, Kim YH.
    J Am Acad Dermatol; 2008 Dec; 59(6):953-7. PubMed ID: 18817999
    [Abstract] [Full Text] [Related]

  • 16. Splenic marginal zone lymphoma, iliac vein thrombosis, and monoclonal immunoglobulin Mkappa antiphospholipid antibody with Annexin A5 interaction.
    Martin SE, Abel RF.
    Leuk Lymphoma; 2006 Sep; 47(9):1994-6. PubMed ID: 17065025
    [No Abstract] [Full Text] [Related]

  • 17. [Splenic marginal zone lymphoma associated with antiphospholipid antibodies].
    Yokoi T, Mori S, Sugimoto H, Komiyama Y, Uemura Y, Tanijiri R, Nakai K, Matsumoto N, Zen K, Amakawa R, Kishimoto Y, Ieko M, Takahashi H, Fukuhara S.
    Rinsho Ketsueki; 2004 Oct; 45(10):1095-9. PubMed ID: 15553043
    [Abstract] [Full Text] [Related]

  • 18. Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab.
    Kyrtsonis MC, Siakantaris MP, Kalpadakis C, Dimopoulou MN, Vassilakopoulos TP, Kontopidou FN, Antoniou C, Korkolopoulou P, Panayiotidis P, Pangalis GA.
    Eur J Haematol; 2006 Oct; 77(4):300-3. PubMed ID: 16856917
    [Abstract] [Full Text] [Related]

  • 19. The role of rituximab in the treatment of canine lymphoma: an ex vivo evaluation.
    Impellizeri JA, Howell K, McKeever KP, Crow SE.
    Vet J; 2006 May; 171(3):556-8. PubMed ID: 16624725
    [Abstract] [Full Text] [Related]

  • 20. Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma.
    Lossos IS, Morgensztern D, Blaya M, Alencar A, Pereira D, Rosenblatt J.
    Leuk Lymphoma; 2007 Aug; 48(8):1630-2. PubMed ID: 17701596
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.